Generics 18

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Desvenlafaxine succinate monohydrate manufacturers

18 products found

Filters

18 products found

desvenlafaxine succinate monohydrate

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

desvenlafaxine succinate monohydrate

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20045

Manufacturer usually replies in 2 days

desvenlafaxine succinate monohydrate + clonazepam

Tablets 50 mg + 0.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20045

Manufacturer usually replies in 2 days

desvenlafaxine succinate monohydrate

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20045

Manufacturer usually replies in 2 days

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17881
Quality, price, innovative molecules as well as the established validity of the active ingredients selected by the doctors due to their effectiveness and reliability, are key factors that enable the company to place its products in the hands of more than 1.5 million patients every month. It is dedicated to the development of pharmaceuticals for psychiatry, cardiology, diabetes, dentistry, gynecology, and oncology, among others.

Manufacturer usually replies in 4 days

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

Manufacturer usually replies in 6 days

desvenlafaxine succinate monohydrate

Tablets 100 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

Manufacturer usually replies in 9 days

desvenlafaxine succinate monohydrate

Tablets, film coated 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

desvenlafaxine succinate monohydrate

Tablets, extended release (ER) 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17691

Manufacturer usually replies in 7 days

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

desvenlafaxine succinate monohydrate

Tablets, prolonged release (PR) 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Available for
Distribution only
Manufacturer #16240
It is a laboratory that produces several product lines, such as allergy, cardiology, clinic, dermatology, gastroenterology, geriatrics, neurology, pediatrics, psychiatry, and urology, among others.

Manufacturer usually replies in 6 days

desvenlafaxine succinate monohydrate

Tablets, prolonged release (PR) 50mg, 100mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, EU GMP
Manufacturer #20767
It is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. They have a broad technology base covering OSD, liquids, creams, ointments, and sterile (injectable) across all key therapeutic areas. They have a further 90+ products (INNs) under development and registration. They aim to improve the quality of life by increasing access to high-quality and affordable medicines.

Manufacturer usually replies in 11 days

desvenlafaxine succinate monohydrate

Tablets, sustained release (SR) 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20027

Manufacturer usually replies in 12 days

desvenlafaxine succinate monohydrate

Tablets, sustained release (SR) 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20027

Manufacturer usually replies in 12 days

desvenlafaxine succinate monohydrate

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20194

desvenlafaxine succinate monohydrate

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

desvenlafaxine succinate monohydrate

Tablets, film coated 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days